HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sustained response to low-dose imatinib mesylate in a patient with chronic myelomonocytic leukemia with t(5;12)(q33;p13).

AuthorsJuyoung Shin, Myungshin Kim, Dae-Bum Kim, Ju-Ok Yeom, Hyo-Jin Lee, Seok-Goo Cho
JournalActa haematologica (Acta Haematol) Vol. 119 Issue 1 Pg. 57-9 ( 2008) ISSN: 1421-9662 [Electronic] Switzerland
PMID18268406 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Benzamides
  • Child
  • Child, Preschool
  • Chromosomes, Human, Pair 12
  • Chromosomes, Human, Pair 5
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelomonocytic, Chronic (drug therapy, genetics)
  • Male
  • Middle Aged
  • Piperazines (therapeutic use)
  • Pyrimidines (therapeutic use)
  • Translocation, Genetic
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: